A retrospective study comparing the toxicity and all-cause mortality associated with first line oral systemic therapy for mCPRC patients
Latest Information Update: 20 Aug 2020
At a glance
- Drugs Abiraterone acetate (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Aug 2020 New trial record
- 26 Jul 2020 Primary endpoint has been met. (all cause mortality)
- 26 Jul 2020 Results presented at the 35th Congress of the European Association of Urology